Skip to main content

Home/ PHE - Resources/ Group items tagged mount-sinai

Rss Feed Group items tagged

Dennis OConnor

Mount Sinai Lab 100; reimagining how healthcare is delivered - 0 views

  •  
    Lab100 gives patients a comprehensive health risk assessment and biometric screening. The goal is to empower patients to track their health over time and to learn how their behavior and lifestyle are impacting their health in a very tangible way.
Dennis OConnor

Mt. Sinai Merger Shuts New York's Integrative Medicine "Crown Jewel" - 0 views

  •  
    Kligler and I spoke at length about the turns of events leading to the decision. At the core of our exchange was the vulnerability of these stand-alone clinics amidst leadership changes and system mergers. I shared that I had recently interviewed his frequent colleague, University of Arizona Center for Integrative Medicine's executive director Victoria Maizes, MD about the shutdown of ACIM's Phoenix-based integrative health clinic. Maizes had referenced what she viewed as a parallel with the Continuum story. In both cases, the clinics seemed to be collateral damage to a larger merger with a dominant player who didn't have much interest in the field.
Dennis OConnor

Coronavirus Treatment: Hundreds of Scientists Scramble to Find One - The New York Times - 0 views

  • Working at a breakneck pace, a team of hundreds of scientists has identified 50 drugs that may be effective treatments for people infected with the coronavirus.
  • Quantitative Biosciences Institute Coronavirus Research Group
  • Mount Sinai Hospital in New York and at the Pasteur Institute in Paris
  • ...8 more annotations...
  • no antiviral drug proven to be effective against the virus
  • If the research effort succeeds, it will be a significant scientific achievement: an antiviral identified in just months to treat a virus that no one knew existed until January.
  • Roche Pharma Research and Early Development
  • Quantitative Biosciences Institute
  • Global Health and Emerging Pathogens Institute at the Icahn School of Medicine at Mount Sinai Hospital.
  • Pasteur Institute in Paris
  • In February, a team of researchers found that remdesivir could eliminate the coronavirus from infected cells. Since then, five clinical trials have begun to see if the drug will be safe and effective against Covid-19 in people.
  • On Saturday, Stanford University researchers reported using the gene-editing technology Crispr to destroy coronavirus genes in infected cells.
  •  
    Recommended by DeAunne Denmark, MD, PhD - Magnificent resource
Dennis OConnor

Covid-19 Antibody Test, Seen as Key to Reopening Country, Does Not Yet Deliver - The Ne... - 0 views

  •  
    DeAunne Denmark, MD, PhD: "To date, the FDA has granted EUA for only these 4 companies: Cellex, Ortho Clinical Diagnostics, Chembio Diagnostic Systems and the Mount Sinai Laboratory. Really looking forward to the validation and head-to-head comparison data promised here from the FDA, Chan Zuckerberg (supposedly this week?), and others. That should be telling... "
Dennis OConnor

Mt. Sinai Lab100 - 0 views

  •  
    Part clinic, part research lab, Lab100 uses precision diagnostics to empower patients and help scientists advance our understanding of human health.
Dennis OConnor

Building a Secure Biomedical Data Sharing Decentralized App (DApp): Tutorial - 0 views

  •  
    ABSTRACT Decentralized apps (DApps) are computer programs that run on a distributed computing system, such as a blockchain network. Unlike the client-server architecture that powers most internet apps, DApps that are integrated with a blockchain network can execute app logic that is guaranteed to be transparent, verifiable, and immutable. This new paradigm has a number of unique properties that are attractive to the biomedical and health care communities. However, instructional resources are scarcely available for biomedical software developers to begin building DApps on a blockchain. Such apps require new ways of thinking about how to build, maintain, and deploy software. This tutorial serves as a complete working prototype of a DApp, motivated by a real use case in biomedical research requiring data privacy. We describe the architecture of a DApp, the implementation details of a smart contract, a sample iPhone operating system (iOS) DApp that interacts with the smart contract, and the development tools and libraries necessary to get started. The code necessary to recreate the app is publicly available.
Dennis OConnor

N1: wellness by experiment - Down App to experiment - 0 views

  •  
    N1: wellness by experiment 17+ Back your wellness with data INGH Available on iOS only You can use this app to join a clinical trial on cognition. Comparing 2 treatments using caffeine (50-400 mg) and caffeine (50-400 mg) in combination with L-theanine (250 mg) : L-theanine is a naturally occurring amino acid most commonly found in green tea. I've downloaded the app will join the study. Interesting screen by screen informed consent process. Will report what I discover at an upcoming Apollo Meeting.
Dennis OConnor

INGH Institute for Next Generation Healthcare - 0 views

  • We offer an inspirational ecosystem for healthcare professionals, patients, scientists and entrepreneurs determined to close the gap between health and care at a time when the failures of the current healthcare system call for an innovation movement to bring transformational change.
  • All our innovations will have the human experience at heart
  • The Institute for Next Generation Healthcare at Mount Sinai launched an ambitious project called LymeMIND
  •  
    DeAunne Denmark, MD, PhD - OUR CORE PREMISE: To improve health, we must close the gap between what we know and what we do. "INGH has a new facility and venture that is the best I've seen anywhere to get a whole slew of high-resolution data collected in one shot. And supposedly, it is "not that expensive"...
Dennis OConnor

Diane Meier | Biography | Mount Sinai - New York - 1 views

  •  
    Recommended by DeAunne Denmark MD PhD: "Most people who need palliative care are not dying. They are living, and often for a very long time with serious illnesses.... They have a tremendous burden of suffering and caregiver distress, but they are not dying. Palliative care was an answer to that gap. It was recognizing that living with a serious illness nowadays is almost always a chronic disease. No matter how long people have to live, they deserve the same attention to quality of life, treatment of symptoms, management of depression, support for their families, and support for social issues like financing and housing. It should be based on need, not prognosis." -- Diane Meier, MD
1 - 9 of 9
Showing 20 items per page